用促黄体生成素释放激素类似物布舍瑞林治疗晚期前列腺癌
[Treatment of advanced cancer of the prostate with an analog of LHRH, buserelin].
作者信息
Wenderoth U K, Jacobi G H
出版信息
Ann Urol (Paris). 1986;20(2):95-7.
PMID:3087269
Abstract
Patients with metastatic prostatic cancer were treated by means of an LHRH agonist, Buserelin, by nasal administration. The serum testosterone levels were permanently decreased to castration levels in all patients. The objective response rate (CR + PR) was 50%.
摘要
转移性前列腺癌患者通过鼻内给药的促黄体生成素释放激素（LHRH）激动剂布舍瑞林进行治疗。所有患者的血清睾酮水平均永久性降低至去势水平。客观缓解率（完全缓解 + 部分缓解）为50%。
Zotero 插件